Research graph
References from Filgotinib effective across the axSpA spectrum in phase III trial. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.ard.2026.06.024
10.1016/j.ard.2026.06.024 · 2026 · External reference
